# GlaxoSmithKline, LLC. - Inspection Records

Source: https://www.keypedia.com/companies/glaxosmithkline-llc/7ab59069-93ea-4898-a74a-874992c27286

> Inspection records and compliance data for GlaxoSmithKline, LLC. in Conshohocken, Pennsylvania. Access full analysis and detailed observations.

---

## Details

- Name: GlaxoSmithKline, LLC.
- FEI Number: 3004055938
- City: Conshohocken
- State: Pennsylvania
- Country Name: United States
- Address Line 1: 893 Schuylkill River Rd Bldg 40
- Zip Code: 19428

## Related Documents

- [483 - GlaxoSmithKline, LLC. - 2026-01-25](https://www.keypedia.com/records/483/glaxosmithkline-llc/d1a3cd11-06e2-4ab5-81cb-47552bfe467a) — source: FDA, date: January 25, 2026
- [FDA Inspection 1274978 - GlaxoSmithKline, LLC. - 2025-03-07](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/b8f525fd-c7f3-4be7-96cb-3b6521628f55) — source: FDA, date: March 7, 2025
- [483 - GlaxoSmithKline, LLC. - 2024-09-25](https://www.keypedia.com/records/483/glaxosmithkline-llc/2e61f4bb-ceab-409d-9c7e-ad3739096580) — source: FDA, date: September 25, 2024
- [FDA Inspection 1261906 - GlaxoSmithKline, LLC. - 2024-09-25](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/a2084345-5a0c-4a87-8363-0d2bd8669d45) — source: FDA, date: September 25, 2024
- [FDA Inspection 1211050 - GlaxoSmithKline, LLC. - 2023-06-20](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/8485f852-2d88-42c0-9721-aadfe170918e) — classification: No Action Indicated (NAI), source: FDA, date: June 20, 2023
- [FDA Inspection 1043309 - GlaxoSmithKline, LLC. - 2018-01-26](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/0b5167aa-cc71-4870-ab00-b2a540d138b4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 26, 2018
- [FDA Inspection 927643 - GlaxoSmithKline, LLC. - 2015-05-08](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/fbc0c9fa-7686-48d1-9dc5-f3490f633878) — classification: No Action Indicated (NAI), source: FDA, date: May 8, 2015
- [FDA Inspection 730716 - GlaxoSmithKline, LLC. - 2011-06-07](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/3c7723f0-8902-4683-af32-1698224dcb83) — classification: No Action Indicated (NAI), source: FDA, date: June 7, 2011

## Related Companies

- [IDT Biologika GmbH](https://www.keypedia.com/companies/idt-biologika-gmbh/ec3af185-e1cd-4ce4-9268-6cbfb25fa986)
- [Merck Teknika LLC](https://www.keypedia.com/companies/merck-teknika-llc/64024257-325c-45de-a5c2-70cbe8abecf5)
- [GlaxoSmithKline Manufacturing S.p.A.](https://www.keypedia.com/companies/glaxosmithkline-manufacturing-spa/11f7427f-c02e-4b80-91dd-f90cbe9b90a9)
- [Hainan Shuangcheng Pharmaceuticals Co Ltd](https://www.keypedia.com/companies/hainan-shuangcheng-pharmaceuticals-co-ltd/920c7235-0cdd-4c0a-884c-43e1f605c1c6)
- [Shandong New Time Pharmaceutical Co. Ltd.](https://www.keypedia.com/companies/shandong-new-time-pharmaceutical-co-ltd/470fe860-121a-4594-b9a5-e6bf05ce1926)
- [Valdepharm](https://www.keypedia.com/companies/valdepharm/9a1bab54-2984-4dec-8384-e3aaa423bda7)
- [Nordmark Arzneimittel GMBH & Co. KG](https://www.keypedia.com/companies/nordmark-arzneimittel-gmbh-co-kg/871eb270-8517-4646-923a-b4d2eb0ea73b)
- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)
- [Baxalta Belgium Manufacturing SA](https://www.keypedia.com/companies/baxalta-belgium-manufacturing-sa/61b3acce-a147-4f22-b13a-34bb436ea8e9)
- [Avara Liscate Pharmaceutical Services SPA](https://www.keypedia.com/companies/avara-liscate-pharmaceutical-services-spa/2dee93ec-8dc9-420b-b20d-da7f8948cf04)

## Related Officers

- [Investigator](https://www.keypedia.com/people/anita-r-michael/b7699b1a-4157-477e-8226-2cfc906fc61d)
- [Zhen Ren, Ph.D., Staff Fellow](https://www.keypedia.com/people/zhen-ren-phd-staff-fellow/00154253-06a4-42c5-bfe3-b887233c41fb)
- [Priscilla Acosta, M.S., Pharmaceutical Scientist](https://www.keypedia.com/people/priscilla-acosta-ms-pharmaceutical-scientist/026090e2-9b0e-47ef-9578-4107b8342f38)